Abstract: Described herein are devices for delivering pharmaceutical compositions to individuals in need thereof. Also described herein are methods of using the devices described herein to deliver pharmaceutical compositions to individuals in need thereof.
Abstract: Devices for intranasal administration of naloxone are disclosed. The devices comprise a foam applicator and are configured to locate an applicator comprising a naloxone composition. in proximity to the middle turbinate and/or inferior turbinate. Naloxone can be delivered to the nasal mucosa by squeezing the nostril against the applicator. The device and methods of using the devices can be used to treat an opioid overdose.
Type:
Grant
Filed:
February 28, 2022
Date of Patent:
June 25, 2024
Assignee:
Pocket Naloxone Corp.
Inventors:
Ashanthi Mathai, Michael Frost, Serena Kim, Franciscus Koppenhagen, Seth Oringher
Abstract: Devices for intranasal administration of naloxone are disclosed. The devices comprise a foam applicator and are configured to locate an applicator comprising a naloxone composition. in proximity to the middle turbinate and/or inferior turbinate. Naloxone can be delivered to the nasal mucosa by squeezing the nostril against the applicator. The device and methods of using the devices can be used to treat an opioid overdose.
Type:
Grant
Filed:
August 31, 2021
Date of Patent:
March 22, 2022
Assignee:
Pocket Naloxone Corp.
Inventors:
Ashanthi Mathai, Michael Frost, Serena Kim, Franciscus Koppenhagen, Seth Oringher
Abstract: Described herein are devices for delivering pharmaceutical compositions to individuals in need thereof. Also described herein are methods of using the devices described herein to deliver pharmaceutical compositions to individuals in need thereof.
© 2025 Justia
